Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LENALIDOMIDE Cause Acute lymphocytic leukaemia? 342 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 342 reports of Acute lymphocytic leukaemia have been filed in association with LENALIDOMIDE (LENALIDOMIDE). This represents 0.1% of all adverse event reports for LENALIDOMIDE.

342
Reports of Acute lymphocytic leukaemia with LENALIDOMIDE
0.1%
of all LENALIDOMIDE reports
63
Deaths
112
Hospitalizations

How Dangerous Is Acute lymphocytic leukaemia From LENALIDOMIDE?

Of the 342 reports, 63 (18.4%) resulted in death, 112 (32.7%) required hospitalization, and 29 (8.5%) were considered life-threatening.

Is Acute lymphocytic leukaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LENALIDOMIDE. However, 342 reports have been filed with the FAERS database.

What Other Side Effects Does LENALIDOMIDE Cause?

Diarrhoea (27,576) Fatigue (22,956) Death (19,213) Off label use (17,017) Rash (15,794) Pneumonia (14,807) Plasma cell myeloma (14,191) Neuropathy peripheral (10,215) White blood cell count decreased (9,996) Constipation (9,635)

What Other Drugs Cause Acute lymphocytic leukaemia?

DEXAMETHASONE (224) BLINATUMOMAB (223) CYCLOPHOSPHAMIDE (219) PONATINIB (210) VINCRISTINE (197) METHOTREXATE (192) DOXORUBICIN (148) IMATINIB (132) CYTARABINE (126) TISAGENLECLEUCEL (96)

Which LENALIDOMIDE Alternatives Have Lower Acute lymphocytic leukaemia Risk?

LENALIDOMIDE vs LENIOLISIB LENALIDOMIDE vs LENOGRASTIM LENALIDOMIDE vs LENVATINIB LENALIDOMIDE vs LEPONEX LENALIDOMIDE vs LERCANIDIPINE

Related Pages

LENALIDOMIDE Full Profile All Acute lymphocytic leukaemia Reports All Drugs Causing Acute lymphocytic leukaemia LENALIDOMIDE Demographics